Burcu Caner

6PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2026
Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study.

|Feb 27, 2026
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.

Sibel Oyucu Orhan, Bedrettin Orhan, Yağmur Çakır

|Sep 27, 2025
Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers.

Sibel Oyucu Orhan, Bedrettin Orhan, Şeyma Esenbuğa

|Jun 30, 2025
Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast.

Seda Sali, Mursel Sali, Burcu Caner

|Nov 26, 2024
Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study.

Sercan Ön, Barış Köksal, Zafer Arık

|Feb 21, 2022
Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma.

Burcu Caner, Hulya Ertas, Birol Ocak

Pageof 1

Frequent Collaborators

4 joint publications

Birol Ocak

3 joint publications

Erdem Cubukcu

3 joint publications

Turkkan Evrensel

3 joint publications

Ahmet Bilgehan Sahin